Large animal model of chronic pulmonary hypertension

ASAIO Journal

Volumn 54, Issue 4, 2008, Pages 396-400

  Sato, Hitoshi ^a   Hall, Candice M ^a   Griffith, Grant W ^a   Johnson, Kent F ^b   McGillicuddy, John W ^a   Bartlett, Robert H ^a   Cook, Keith E ^a,c  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL MODEL; ARTIFICIAL LUNG; CARDIAC OUTPUT; CHRONIC LUNG DISEASE; HEART FAILURE; LOW RATES; LUNG DISEASE; PULMONARY ARTERY; PULMONARY HYPERTENSION; RIGHT VENTRICULAR; SEPHADEX; SHEEP MODEL;

ARTIFICIAL ORGANS; BLOOD PRESSURE; ION EXCHANGE; PATHOLOGY; PULMONARY DISEASES; WOOL;

BIOLOGICAL ORGANS;

SEPHADEX; DEXTRAN; DYES, REAGENTS, INDICATORS, MARKERS AND BUFFERS; OXYGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ARTIFICIAL LUNG; COMPARATIVE STUDY; CONTROLLED STUDY; HEART FAILURE; HEART OUTPUT; HEART RIGHT VENTRICLE HYPERTROPHY; LUNG ARTERY PRESSURE; LUNG VASCULAR RESISTANCE; MALE; MORTALITY; NONHUMAN; PULMONARY ARTERY OCCLUSION PRESSURE; PULMONARY HYPERTENSION; SHEEP; ANIMAL; CHRONIC DISEASE; DISEASE MODEL; HEMODYNAMICS; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; VASCULAR RESISTANCE;

ANIMALS; CARDIAC OUTPUT; CHRONIC DISEASE; DEXTRANS; DISEASE MODELS, ANIMAL; HEMODYNAMICS; HYPERTENSION, PULMONARY; HYPERTROPHY, RIGHT VENTRICULAR; INDICATORS AND REAGENTS; OXYGEN; SHEEP; VASCULAR RESISTANCE;

EID: 51149111227     PISSN: 10582916     EISSN: None     Source Type: Journal    
DOI: 10.1097/MAT.0b013e31817efa85     Document Type: Article

References (24)

1. Sato H, Griffith GW, Hall CM, et al: Seven day artificial lung testing in an in-parallel configuration. Ann Thorac Surg 84: 988-994, 2007.
2. Sato H, Hall CM, Lafayette NG, et al: Thirty-day, in parallel artificial lung testing in sheep. Ann Thorac Surg 84: 1136- 1143, 2007.
3. Zwischenberger JB, Wang D, Lick SD, et al: The paracorporeal artificial lung improves 5-day outcomes from lethal smoke/burn induced acute respiratory distress syndrome in sheep. Ann Thorac Surg 74: 1011-1018, 2002.
4. Weitzenblum E, Ehrhart M, Rasaholinjanahary J, Hirth C: Pulmonary hemodynamics in idiopathic pulmonary fibrosis and other interstitial pulmonary disease. Respiration 44: 118-127, 1983.
5. Lettieri CJ, Nathan SD, Barnett SD, et al: Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis. Chest 129: 746-752, 2006.
6. Thabut G, Mal H, Castier Y, et al: Survival benefit of lung transplantation for patients with idiopathic pulmonary fibrosis. J Thorac Cardiovasc Surg 126: 469-475, 2003.
7. Scharf SM, Keller CA, Weg IL: Lung volume reduction surgery for emphysema, in Fessler HE, Rielly JJ, Sugarbaker DJ (eds), Lung Biology in Health and Disease, New York, Informa Health Care, 2004, pp. 65-98.
8. Thabut G, Dauriat G, Stern JB, et al: Pulmonary hemodynamics in advanced COPD candidates for lung volume reduction surgery or lung transplantation. Chest 127: 1531-1536, 2005.
9. Rocca GD, Pugliese F, Antonini M, et al: Hemodynamics during inhaled nitric oxide in lung transplant candidates. Transplant Proc 29: 3367-3370, 1997.
10. Vizza CD, Lynch JP, Ochoa LL, et al: Right and left ventricular dysfunction in patients with severe pulmonary disease. Chest 113: 576-583, 1998.
11. Venuta F, Rendina EA, Rocca GD, et al: Pulmonary hemodynam-ics contribute to indicate priority for lung transplantation in patients with cystic fibrosis. J Thorac Cardiovasc Surg 119: 682-689, 2000.
12. Rich S. NIH registry on primary pulmonary hypertension: baseline characteristics of the patients enrolled, in Fishman AP (ed), The Pulmonary Circulation: Normal and Abnormal, Philadelphia, University of Pennsylvania Press, 1990, pp. 451-457.
13. Ionescu AA, Payne N, Obieta-Fresnedo I, et al: Subclinical right ventricular dysfunction in cystic fibrosis. A study using tissue Doppler echocardiography. Am J Resp Crit Care Med 163: 1212-1218, 2001.
14. Saito H, Dambara T, Aiba M, et al: Evaluation of cor pulmonale on a modified short-axis section of the heart by magnetic resonance imaging. Am Rev Respir Dis 146: 1576-1581, 1992.
15. Perkett EA, Brigham KL, Meyrick B: Continuous air embolization into sheep causes sustained pulmonary vasoreactivity. Am J Pathol 132: 444-454, 1988.
16. Perkett EA, Davidson JM, Meyrick B: Sequence of structural change and elastin peptide release during vascular remodeling in sheep with chronic pulmonary hypertension induced by air embolization. Am J Pathol 139: 1319-1332, 1999.
17. Meyrick BO, Perkett EA: The sequence of cellular and hemody-namic changes of chronic pulmonary hypertension induced by hypoxia and other stimuli. Am Rev Respir Dis 140: 1486-1489, 1989.
18. Irwin S, Grondelle A, McCullough R, et al: A model of embolic chronic pulmonary hypertension in the dog. J Appl Physiol 56: 810-815, 1984.
19. Kim H, Yung GL, Marsh JJ, et al: Endothelin mediates pulmonary vascular remodeling in a canine model of chronic embolic pulmonary hypertension. Eur Respir J 15: 640-648, 2000.
20. Sato H, McGillicuddy JW, Griffith GW, et al: Effects of artificial lung compliance on in vivo pulmonary system hemodynamics. ASAIO J 52: 248-256, 2006.
21. West JB: Respiratory Physiology, The Essentials. Baltimore, Lip-pincott, Williams, & Wilkins, 2005.
22. Horsfield K: Morphometry of the small pulmonary arteries in man. Circ Res 42: 593-597, 1978.
23. Young I, Mazzone RW, Wagner PD: Identification of functional lung unit in the dog by grades vascular embolization. J Appl Physiol 49: 132-141, 1980.
24. Delcroix M, Mélot C, Vachiéry JL, et al: Effects of embolus size on hemodynamics and gas exchange in canine embolic pulmonary hypertension. J Appl Physiol 69: 2254-2261, 1990.